Becton, Dickinson & Co.


-0.00 (-0.00%) Today
1 Day1D

5 Days5D

1 Month1M

6 Months6M


1 Year1Y

2 Years2Y

5 Years5Y



Becton, Dickinson & Co. is a medical technology company. The firm engages in the development, manufacture and sale of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. It operates through the following segments: BD Medical, BD Life Sciences and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, and instruments and reagent systems to detect infectious diseases, healthcare-associated infections and cancers. The BD Interventional segment provides vascular, urology, oncology and surgical specialty products to hospitals, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via Homecare business. The company was founded in 1897 and is headquartered in Franklin Lakes, NJ.


Thomas E. Polen




1 Becton Drive Franklin Lakes, NJ, 07417-1880



Market Cap

Becton, Dickinson & Co. News

The top 5 MassDevice stories of the week — August 14, 2020 Aug 14, 2020

COVID-19 continues to batter medical device companies — not to mention the world as a whole. But some of this week’s top five MassDevice stories demonstrate that medtech companies continue to innovate and ink business deals as they look toward a post-pandemic future. Want to hear more about the week’s top news? Executive editor Chris […]

Federal appeals court rejects preemption argument from BD’s Bard Aug 14, 2020

The 9th U.S. Circuit Court of Appeals has handed down an important medical device preemption opinion as it affirmed a $3.6 million award against Becton Dickinson & Co. (NYSE:BDX) subsidiary C.R. Bard in a bellwether lawsuit case over inferior vena cava filters. Bard’s lawyers had argued that when FDA reclassified intravascular filters as Class II devices, the […]

Georgia mayor wants BD sterilization plant shuttered for now Oct 17, 2019

The mayor of Covington, Ga. has asked Becton Dickinson (NYSE:BDX) to temporarily shut down a plant there following a weeklong leak of the gas it uses to sterilize medical devices. A letter from Mayor Ronnie Johnston says that independent air quality tests performed for the city from Sept. 17 to Sept. 24 revealed “particularly high levels of […]

The 20 largest medical device companies in the world Sep 17, 2019

Consolidations continue to transform the roster of largest medical device companies in the world — as evidenced by Medical Design & Outsourcing‘s latest Big 100 list. Overall, Big 100 companies saw $397.5 billion in sales during their most recent fiscal years, up 3.5% from the previous year. As companies continue to combine, smaller companies are…

FDA approves BD’s Venovo venous stent Mar 14, 2019

Becton Dickinson & Co. (NYSE:BDX) said today that the FDA granted pre-market approval for its Venovo stent for treating iliofemoral venous occlusive disease. Franklin Lakes, N.J.-based BD touted Venovo as the first on the U.S. market approved to treat obstructed blood flow in the iliac and femoral veins. “The FDA pre-market approval of the Venovo venous […]